Bio-Techne
TECH
#1794
Rank
NZ$20.83 B
Marketcap
NZ$132.63
Share price
-0.07%
Change (1 day)
28.80%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): NZ$2.04

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is NZ$2.13. In 2025 the company made an earnings per share (EPS) of NZ$0.95 a decrease over its 2024 EPS that were of NZ$1.82.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$2.04114.6%
2025NZ$0.95-48%
2024NZ$1.82-29.58%
2023NZ$2.59-14.97%
2022NZ$3.0524.16%
2021NZ$2.4517.98%
2020NZ$2.08-10.94%
2019NZ$2.34101.57%
2018NZ$1.16-16.99%
2017NZ$1.4045.02%
2016NZ$0.96-20.97%
2015NZ$1.22-14.97%
2014NZ$1.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$34.64 1,523.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$6.57 207.69%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$15.93 646.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$11.16 423.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.62 69.64%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.38-117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ$69.62 3,161.54%๐Ÿ‡บ๐Ÿ‡ธ USA